FibroGen Announces Positive Type C Meeting With The FDA For Roxadustat In Patients With Anemia Associated With Lower-Risk Myelodysplastic Syndromes

RefinitivLess than 1 min read

FibroGen Inc FGEN:

FIBROGEN ANNOUNCES POSITIVE TYPE C MEETING WITH THE FDA FOR ROXADUSTAT IN PATIENTS WITH ANEMIA ASSOCIATED WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Login or create a forever free account to read this news